- Home
- RLMD vs IBG Comparison
RLMD vs IBG Comparison
Compare RLMD & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- IBG
- Stock Information
- Founded
- RLMD 2004
- IBG 2018
- Country
- RLMD United States
- IBG Australia
- Employees
- RLMD N/A
- IBG N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- RLMD Health Care
- IBG Consumer Staples
- Exchange
- RLMD Nasdaq
- IBG Nasdaq
- Market Cap
- RLMD 67.7M
- IBG 75.7M
- IPO Year
- RLMD N/A
- IBG 2024
- Fundamental
- Price
- RLMD $2.09
- IBG $3.92
- Analyst Decision
- RLMD Hold
- IBG Strong Buy
- Analyst Count
- RLMD 2
- IBG 1
- Target Price
- RLMD $1.00
- IBG N/A
- AVG Volume (30 Days)
- RLMD 335.3K
- IBG 5.0M
- Earning Date
- RLMD 11-07-2025
- IBG 11-15-2025
- Dividend Yield
- RLMD N/A
- IBG N/A
- EPS Growth
- RLMD N/A
- IBG N/A
- EPS
- RLMD N/A
- IBG N/A
- Revenue
- RLMD N/A
- IBG $2,931,243.00
- Revenue This Year
- RLMD N/A
- IBG N/A
- Revenue Next Year
- RLMD N/A
- IBG N/A
- P/E Ratio
- RLMD N/A
- IBG N/A
- Revenue Growth
- RLMD N/A
- IBG N/A
- 52 Week Low
- RLMD $0.24
- IBG $1.48
- 52 Week High
- RLMD $3.98
- IBG $9.85
- Technical
- Relative Strength Index (RSI)
- RLMD 55.74
- IBG 61.02
- Support Level
- RLMD $1.98
- IBG $3.61
- Resistance Level
- RLMD $2.27
- IBG $4.10
- Average True Range (ATR)
- RLMD 0.21
- IBG 0.43
- MACD
- RLMD -0.04
- IBG -0.05
- Stochastic Oscillator
- RLMD 64.22
- IBG 49.25
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.